Evidence‐Based Nursing Management of Semi‐Implantable Intrathecal Drug Delivery Systems for Refractory Cancer Pain: Protocol Development and Clinical Evaluation
Comparative evaluation shows improved pain relief and fewer adverse events in patients with refractory cancer pain, indicating the value of standardized intrathecal nursing protocols.
Key Points
To develop an evidence-based nursing protocol for semi-implantable intrathecal drug delivery systems (IDDS) and assess its clinical impact on refractory cancer pain management.
Synthesized 34 best-evidence statements from 2015–2025 literature using the Joanna Briggs Institute (JBI) evidence translation model to construct a perioperative nursing protocol.
Evaluated clinical outcomes in 32 post-implementation patients compared to a baseline cohort of 31 pre-implementation patients.
Protocol implementation significantly increased pain relief rates and patient satisfaction while decreasing overall adverse events and infections (p < 0.05).
Compliance across all 12 nursing quality indicators improved significantly, most notably in home care education (p < 0.001).
Nursing staff achieved significant improvements in IDDS-related knowledge, attitudes, clinical practices, and dressing-change performance (p < 0.001).